|
CN111205216A
|
|
Method for preparing saxagliptin
|
|
CN110878083A
|
|
Purification method of dabigatran etexilate intermediate
|
|
CN110655540A
|
|
Method for synthesizing decitabine intermediate
|
|
CN110229099A
|
|
A method of preparing Sorafenib key intermediate
|
|
CN110128407A
|
|
A kind of preparation method of Dabigatran etexilate key intermediate
|
|
CN109929007A
|
|
The preparation method of Ac-D-2Nal-D-4Cpa-D-3Pal-Ser-4Aph(Hor)-D-4Aph(Cbm)-Leu-Lys(iPr)-Pro-D-Ala-NH2 key dipeptides intermediate
|
|
CN109929012A
|
|
The preparation method of Ac-D-2Nal-D-4Cpa-D-3Pal-Ser-4Aph(Hor)-D-4Aph(Cbm)-Leu-Lys(iPr)-Pro-D-Ala-NH2 key tetrapeptide intermediate
|
|
CN109956886A
|
|
(Z)-[(4- methoxyphenyl) hydrazono-] preparation method of ethyl chloroacetate
|
|
CN109836381A
|
|
The preparation method of polyceptor tyrosine kinase inhibitor and its intermediate
|
|
CN107955061A
|
|
The preparation method of Ac-D-2Nal-D-4Cpa-D-3Pal-Ser-4Aph(Hor)-D-4Aph(Cbm)-Leu-Lys(iPr)-Pro-D-Ala-NH2 key intermediate
|
|
CN109771380A
|
|
Desmethylvenlafaxine hydrochloride drug composition and preparation method thereof
|
|
CN109705139A
|
|
The purification process of C-Met inhibitor intermediate
|
|
CN107556287A
|
|
Canagliflozin intermediate synthetic method
|
|
CN107540646A
|
|
Vilazodone intermediate synthetic method
|
|
CN107674052A
|
|
Vilazodone intermediate 5（1 piperazinyl）The carboxylic acid, ethyl ester synthetic method of 2 benzofuran 2
|
|
CN107325028A
|
|
Fulvestrant side chain intermediate synthetic method
|
|
CN107501159A
|
|
The cyanoindole synthetic method of vilazodone intermediate 3 (4 chlorobutyl) 5
|
|
CN107325143A
|
|
Fulvestrant intermediate synthetic method
|
|
CN107344915A
|
|
The preparation method of linezolid intermediate
|
|
CN107382880A
|
|
The preparation method of Tarceva intermediate
|
